NEW YORK (Reuters Health) – The dopamine agonist pramipexole relieves depressive symptoms in patients with Parkinson’s disease, according to a study published online May 10th in The Lancet…
NEW YORK (Reuters Health) – Dizziness in the elderly is caused by cardiovascular disease in over half of patients seen in primary care, according to new research from…
NEW YORK (Reuters Health) – Pegylated interferon alfa-2a safely reduces HIV-1 load in untreated patients without chronic hepatitis C virus (HCV) infection, according to a report in the…
NEW YORK (Reuters Health) – Intravesical botulinum toxin improves overactive bladder symptoms, but with a significant risk of urinary retention, according to a meta-analysis reported April 19th in…
NEW YORK (Reuters Health) – Statins reduce the risk of new-onset atrial fibrillation after myocardial infarction or revascularization, new data confirm. “This may be yet another reason why…
NEW YORK (Reuters Health) – A single dose of azithromycin cured early syphilis as effectively as the standard painful penicillin injections, in a recent phase III trial. But…
NEW YORK (Reuters Health) – Recombinant human neuregulin-1 (rhNRG-1) improves cardiac function and remodeling in patients with chronic heart failure (CHF), say researchers from the People’s Republic of…
NEW YORK (Reuters Health) – In patients with chronic kidney disease (CKD) and anemia, targeting higher hemoglobin levels with an erythropoietic agent is not helpful and is very…
NEW YORK (Reuters Health) – Amlodipine decreases central systolic blood pressure more effectively when combined with valsartan than with atenolol, French researchers reported online April 19th in Hypertension.…
NEW YORK (Reuters Health) – Adding inhaled treprostinil (Tyvaso) to oral bosentan for pulmonary arterial hypertension (PAH) improves exercise capacity and quality of life, according to a report…